Rocket Pharmaceuticals, Inc.
RCKT
$7.59
-$0.29-3.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -258.75M | -258.08M | -253.26M | -249.31M | -245.60M |
| Total Depreciation and Amortization | 9.38M | 8.95M | 8.32M | 7.68M | 7.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.73M | 32.48M | 32.02M | 30.69M | 29.76M |
| Change in Net Operating Assets | 1.92M | 24.53M | 15.76M | 16.74M | 13.82M |
| Cash from Operations | -209.72M | -192.12M | -197.17M | -194.21M | -194.92M |
| Capital Expenditure | -5.86M | -10.20M | -13.27M | -15.46M | -16.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.57M | 38.97M | 11.37M | -10.86M | -81.63M |
| Cash from Investing | 131.71M | 28.77M | -1.89M | -26.31M | -98.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 185.74M | 3.28M | 192.59M | 191.24M | 208.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 185.74M | 3.28M | 192.59M | 191.24M | 208.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.72M | -160.07M | -6.47M | -29.28M | -84.58M |
